ProfileGDS4132 / 1567686_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 24% 23% 36% 33% 29% 24% 27% 33% 39% 31% 32% 31% 32% 35% 43% 28% 34% 32% 36% 24% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10156.599624
GSM201543Muscle PCOS pioglitazone 12145.160823
GSM201544Muscle PCOS pioglitazone 16192.81236
GSM201545Muscle PCOS pioglitazone 20190.931833
GSM201829Muscle PCOS pioglitazone 23174.162629
GSM201830Muscle PCOS pioglitazon 25157.45424
GSM201831Muscle PCOS pioglitazone 27162.257527
GSM201832Muscle PCOS pioglitazone 3183.863633
GSM201833Muscle PCOS pioglitazone 4193.462139
GSM201834Muscle PCOS pioglitazone 8173.882631
GSM201835Muscle PCOS after pioglitazone 10264.422232
GSM201836Muscle PCOS after pioglitazone 12267.160131
GSM201837Muscle PCOS after pioglitazone 16266.641832
GSM201838Muscle PCOS after pioglitazone 20278.340135
GSM201839Muscle PCOS after pioglitazone 232103.99843
GSM201840Muscle PCOS after pioglitazone 25263.701928
GSM201841Muscle PCOS after pioglitazone 27271.500434
GSM201842Muscle PCOS after pioglitazone 3264.185732
GSM201843Muscle PCOS after pioglitazone 4289.847936
GSM201844Muscle PCOS after pioglitazone 8252.425324